{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:49:58Z","timestamp":1783781398025,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T00:00:00Z","timestamp":1387756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1038\/aps.2013.145","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T09:58:14Z","timestamp":1387792694000},"page":"292-300","source":"Crossref","is-referenced-by-count":37,"title":["Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice"],"prefix":"10.1038","volume":"35","author":[{"given":"Jun","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-kun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-chen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"BFaps2013145_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/DMR-120028426","volume":"36","author":"PP Fu","year":"2004","unstructured":"Fu PP, Xia Q, Lin G, Chou MW . Pyrrolizidine alkaloids \u2014 genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 2004; 36: 1\u201355.","journal-title":"Drug Metab Rev"},{"key":"BFaps2013145_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/mnfr.200900529","volume":"54","author":"M Kempf","year":"2010","unstructured":"Kempf M, Reinhard A, Beuerle T . Pyrrolizidine alkaloids (PAs) in honey and pollen-legal regulation of PA levels in food and animal feed required. Mol Nutr Food Res 2010; 54: 158\u201368.","journal-title":"Mol Nutr Food Res"},{"key":"BFaps2013145_CR3","first-page":"83","volume":"50","author":"E Roeder","year":"1995","unstructured":"Roeder E . Medicinal plants in Europe containing pyrrolizidine alkaloids. Die Pharmazie 1995; 50: 83\u201398.","journal-title":"Die Pharmazie"},{"key":"BFaps2013145_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/toxsci\/65.2.309","volume":"65","author":"BL Copple","year":"2002","unstructured":"Copple BL, Banes A, Ganey PE, Roth RA . Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol Sci 2002; 65: 309\u201318.","journal-title":"Toxicol Sci"},{"key":"BFaps2013145_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.510290615","volume":"29","author":"LD DeLeve","year":"1999","unstructured":"DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999; 29: 1779\u201391.","journal-title":"Hepatology"},{"key":"BFaps2013145_CR6","unstructured":"Mattocks AR . Chemistry and toxicology of pyrrolizidine alkaloids. London, Orlando Fla: Academic Press; 1986."},{"key":"BFaps2013145_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0038-1623063","volume":"39","author":"E Petzinger","year":"2011","unstructured":"Petzinger E . Pyrrolizidine alkaloids and seneciosis in farm animals. Part 1: occurrence, chemistry and toxicology. Tierarztl Prax Ausg G Grosstiere Nutztiere 2011; 39: 221\u201330.","journal-title":"Tierarztl Prax Ausg G Grosstiere Nutztiere"},{"key":"BFaps2013145_CR8","first-page":"95","volume":"8","author":"BL Stegelmeier","year":"1999","unstructured":"Stegelmeier BL, Edgar JA, Colegate SM, Gardner DR, Schoch TK, Coulombe RA, et al. Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat Toxins 1999; 8: 95\u2013116.","journal-title":"J Nat Toxins"},{"key":"BFaps2013145_CR9","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/0006-2952(84)90721-4","volume":"33","author":"WM Lafranconi","year":"1984","unstructured":"Lafranconi WM, Huxtable RJ . Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem Pharmacol 1984; 33: 2479\u201384.","journal-title":"Biochem Pharmacol"},{"key":"BFaps2013145_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/taap.1993.1013","volume":"118","author":"LC Pan","year":"1993","unstructured":"Pan LC, Wilson DW, Lame MW, Jones AD, Segall HJ . COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. Toxicol Appl Pharmacol 1993; 118: 87\u201397.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFaps2013145_CR11","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1039\/j39690001155","volume":"(8)","author":"AR Mattocks","year":"1969","unstructured":"Mattocks AR . Dihydropyrrolizine derivatives from unsaturated pyrrolizidine alkaloids. J Chem Soc C 1969; (8): 1155\u201362.","journal-title":"J Chem Soc C"},{"key":"BFaps2013145_CR12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0090-9556(24)13677-X","volume":"28","author":"G Lin","year":"2000","unstructured":"Lin G, Cui YY, Hawes EM . Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos 2000; 28: 1475\u201383.","journal-title":"Drug Metab Dispos"},{"key":"BFaps2013145_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2011","unstructured":"Lin G, Wang JY, Li N, Li M, Gao H, Ji YA, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 2011; 54: 666\u201373.","journal-title":"J Hepatol"},{"key":"BFaps2013145_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0006-2952(95)02189-2","volume":"51","author":"CC Yan","year":"1996","unstructured":"Yan CC, Huxtable RJ . Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat. Biochem Pharmacol 1996; 51: 375\u20139.","journal-title":"Biochem Pharmacol"},{"key":"BFaps2013145_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1568009043333014","volume":"4","author":"PH Rooney","year":"2004","unstructured":"Rooney PH, Telfer C, McFadyen MC, Melvin WT, Murray GI . The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions. Curr Cancer Drug Targets 2004; 4: 257\u201365.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFaps2013145_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.toxlet.2006.01.007","volume":"164","author":"U Bernauer","year":"2006","unstructured":"Bernauer U, Heinrich-Hirsch B, Tonnies M, Peter\u2013Matthias W, Gundert-Remy U . Characterisation of the xenobiotic\u2013metabolizing cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination. Toxicol Lett 2006; 164: 278\u201388.","journal-title":"Toxicol Lett"},{"key":"BFaps2013145_CR17","doi-asserted-by":"publisher","first-page":"25895","DOI":"10.1074\/jbc.M303125200","volume":"278","author":"J Gu","year":"2003","unstructured":"Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, et al. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 2003; 278: 25895\u2013901.","journal-title":"J Biol Chem"},{"key":"BFaps2013145_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/mol.104.007898","volume":"67","author":"J Gu","year":"2005","unstructured":"Gu J, Cui H, Behr M, Zhang L, Zhang QY, Yang W, et al. In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa. Mol Pharmacol 2005; 67: 623\u201330.","journal-title":"Mol Pharmacol"},{"key":"BFaps2013145_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ki.2008.103","volume":"73","author":"Y Xiao","year":"2008","unstructured":"Xiao Y, Ge M, Xue X, Wang C, Wang H, Wu X, et al. Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity. Kidney Int 2008; 73: 1231\u20139.","journal-title":"Kidney Int"},{"key":"BFaps2013145_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0041-0101(91)90015-J","volume":"29","author":"AR Mattocks","year":"1991","unstructured":"Mattocks AR, Croswell S, Jukes R, Huxtable RJ . Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver. Toxicon 1991; 29: 409\u201315.","journal-title":"Toxicon"},{"key":"BFaps2013145_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0041-0101(89)90117-7","volume":"27","author":"AR Mattocks","year":"1989","unstructured":"Mattocks AR, Jukes R, Brown J . Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon 1989; 27: 561\u20137.","journal-title":"Toxicon"},{"key":"BFaps2013145_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0378-4274(03)00293-5","volume":"145","author":"MW Chou","year":"2003","unstructured":"Chou MW, Wang YP, Yan J, Yang YC, Beger RD, Williams LD, et al. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol Lett 2003; 145: 239\u201347.","journal-title":"Toxicol Lett"},{"key":"BFaps2013145_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1039\/p19770000538","volume":"(5)","author":"WM Hoskins","year":"1977","unstructured":"Hoskins WM, Crout DH . Pyrrolizidine alkaloid analogues. Preparation of semisynthetic esters of retronecine. J Chem Soc Perkin Transact 1 1977; (5): 538\u201344.","journal-title":"J Chem Soc Perkin Transact 1"},{"key":"BFaps2013145_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.104.073353","volume":"312","author":"L Wu","year":"2005","unstructured":"Wu L, Gu J, Cui H, Zhang QY, Behr M, Fang C, et al. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450. J Pharmacol Exp Ther 2005; 312: 35\u201343.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps2013145_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00005344-199707000-00018","volume":"30","author":"Y Kasahara","year":"1997","unstructured":"Kasahara Y, Kiyatake K, Tatsumi K, Sugito K, Kakusaka I, Yamagata S, et al. Bioactivation of monocrotaline by P-450 3A in rat liver. J Cardiovasc Pharmacol 1997; 30: 124\u201329.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFaps2013145_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/(SICI)1099-0461(1998)12:3<157::AID-JBT4>3.0.CO;2-K","volume":"12","author":"MJ Reid","year":"1998","unstructured":"Reid MJ, Lame MW, Morin D, Wilson DW, Segall HJ . Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes. J Biochem Mol Toxicol 1998; 12: 157\u201366.","journal-title":"J Biochem Mol Toxicol"},{"key":"BFaps2013145_CR27","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1021\/tx0340302","volume":"16","author":"G Lin","year":"2003","unstructured":"Lin G, Cui YY, Liu XQ . Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Chem Res Toxicol 2003; 16: 768\u201374.","journal-title":"Chem Res Toxicol"},{"key":"BFaps2013145_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/hep.21937","volume":"47","author":"YM Wu","year":"2008","unstructured":"Wu YM, Joseph B, Berishvili E, Kumaran V, Gupta S . Hepatocyte transplantation and drug-induced perturbations in liver cell compartments. Hepatology 2008; 47: 279\u201387.","journal-title":"Hepatology"},{"key":"BFaps2013145_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/00498259509061850","volume":"25","author":"SJ Baldwin","year":"1995","unstructured":"Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ . Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 1995; 25: 261\u201370.","journal-title":"Xenobiotica"},{"key":"BFaps2013145_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/hmg\/dds468","volume":"2","author":"Y Kazuki","year":"2013","unstructured":"Kazuki Y, Kobayashi K, Aueviriyavit S, Oshima T, Kuroiwa Y, Tsukazaki Y, et al. Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. Human Mol Genet 2013; 2: 578\u201392.","journal-title":"Human Mol Genet"},{"key":"BFaps2013145_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3181\/00379727-124-31748","volume":"124","author":"Y Hayashi","year":"1967","unstructured":"Hayashi Y, Lalich JJ . Renal and pulmonary alterations induced in rats by a single injection of monocrotaline. Exp Biol Med (Maywood) 1967; 124: 392\u20136.","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFaps2013145_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0014-4800(83)90066-7","volume":"39","author":"T Kurozumi","year":"1983","unstructured":"Kurozumi T, Tanaka K, Kido M, Shoyama Y . Monocrotaline-induced renal lesions. Exp Mol Pathol 1983; 39: 377\u201386.","journal-title":"Exp Mol Pathol"},{"key":"BFaps2013145_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/hep.510310224","volume":"31","author":"XD Wang","year":"2000","unstructured":"Wang XD, Kanel GC, DeLeve LD . Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology 2000; 31: 428\u201334.","journal-title":"Hepatology"},{"key":"BFaps2013145_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0009-2797(90)90031-H","volume":"76","author":"AR Mattocks","year":"1990","unstructured":"Mattocks AR, Jukes R . Trapping and measurement of short-lived alkylating agents in a recirculating flow system. Chem Biol Interac 1990; 76: 19\u201330.","journal-title":"Chem Biol Interac"},{"key":"BFaps2013145_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1021\/tx025605i","volume":"16","author":"Q Xia","year":"2003","unstructured":"Xia Q, Chou MW, Kadlubar FF, Chan PC, Fu PP . Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Chem Res Toxicol 2003; 16: 66\u201373.","journal-title":"Chem Res Toxicol"},{"key":"BFaps2013145_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/ijerph2005010074","volume":"2","author":"YP Wang","year":"2005","unstructured":"Wang YP, Fu PP, Chou MW . Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Int J Environ Res Public Health 2005; 2: 74\u20139.","journal-title":"Int J Environ Res Public Health"},{"key":"BFaps2013145_CR37","doi-asserted-by":"publisher","first-page":"25895","DOI":"10.1074\/jbc.M303125200","volume":"278","author":"J Gu","year":"2003","unstructured":"Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, et al. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 2003; 278: 25895\u2013901.","journal-title":"J Biol Chem"},{"key":"BFaps2013145_CR38","doi-asserted-by":"publisher","first-page":"13480","DOI":"10.1074\/jbc.M212087200","volume":"278","author":"CJ Henderson","year":"2003","unstructured":"Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, et al. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 2003; 278: 13480\u20136.","journal-title":"J Biol Chem"},{"key":"BFaps2013145_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0090-9556(24)15274-9","volume":"27","author":"MA Gibbs","year":"1999","unstructured":"Gibbs MA, Thummel KE, Shen DD, Kunze KL . Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression. Drug Metab Dispos 1999; 27: 180\u20137.","journal-title":"Drug Metab Dispos"},{"key":"BFaps2013145_CR40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1124\/dmd.31.6.755","volume":"31","author":"A Westlind-Johnsson","year":"2003","unstructured":"Westlind-Johnsson A, Malmebo S, Johansson A, Otter C, Andersson TB, Johansson I, et al. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos 2003; 31: 755\u201361.","journal-title":"Drug Metab Dispos"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2013145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2013145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2013145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:48:25Z","timestamp":1746089305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2013145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,23]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["BFaps2013145"],"URL":"https:\/\/doi.org\/10.1038\/aps.2013.145","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,23]]}}}